AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade

Hypertension

Volumn 40, Issue 4, 2002, Pages 516-520

  Widdop, Robert E ^a   Matrougui, Khalid ^b   Levy, Bernard I ^c   Henrion, Daniel ^b  

^a MONASH UNIVERSITY   (Australia)

^b INSERM   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Muscle, smooth, vascular; Receptors, angiotensin; Vasodilation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; CANDESARTAN HEXETIL; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; OLIGOPEPTIDE; TETRAZOLE DERIVATIVE; VASOCONSTRICTOR AGENT;

ANGIOTENSIN BLOOD LEVEL; ANIMAL TISSUE; ARTERIOGRAPHY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; EVOKED RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REPRODUCIBILITY; STIMULUS RESPONSE; VASOCONSTRICTION; VASODILATATION; ANIMAL; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG ANTAGONISM; IN VITRO STUDY; KINETICS; MESENTERIC ARTERY; PHYSIOLOGY; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; MALE; MESENTERIC ARTERIES; OLIGOPEPTIDES; RATS; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; REPRODUCIBILITY OF RESULTS; TETRAZOLES; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0036771844     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000033224.99806.8A     Document Type: Article

References (34)

1. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor in cardiovascular and renal disease. Hypertension. 1999;33:613-621.
2. Senbonmatsu T, Ichihara S, Price E, Gaffney FA, Inagami T. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest. 2000;106:R25-R29.
3. Ichihara S, Senbonmatsu T, Price E, Ichiki T, Gaffney FA, Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation. 2001;104:346-351.
4. Akishita M, Masaru I, Wu L, Zhang L, Ouchi Y, Dzau VJ, Horiuchi M. Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation. 2000;102:1684-1689.
5. 2 subtype receptors prevents the effect of angiotensin II on rat vascular structure. J Clin Invest. 1996;98:418-425.
6. 2) receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest. 1997;100:264-269.
7. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998;31:349-355.
8. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T. Angiotensin II type 2 overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999;104:925-935.
9. 2 receptor in blood pressure regulation and therapeutic implications. Am J Hypertens. 2001;14:98S-102S.
10. 2 receptor stimulation enhances antihypertensive effect of AT1 receptor antagonist in hypertensive rats. Hypertension. 1999;34:1112-1116.
11. 2 receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension. 1999;34:659-665.
12. Matrougui K, Levy BI, Henrion D. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Br J Pharmacol. 2000;130:521-526.
13. 2 receptor and Ca2+-activated (Bkca) channels. Hypertension. 2001;37:301-307.
14. 2 receptors in Angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension. 1999;33:366-372.
15. Bonnet F, Cooper ME, Carey RM, Casley D, Cao Z. Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin infusion. J Hypertens. 2001;19:1075-1081.
16. De Gasparo M, Levens N. Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensin-converting enzyme? Pharmacol Toxicol. 1998;82:257-271.
17. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type 2 receptor gene in mice. Nature. 1995;377:744-747.
18. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
19. 2 receptors. Br J Pharmacol. 1998;125:1429-1436.
20. Liu Y, Yang X, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 2 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest. 1997;99:1926-1935.
21. 2 receptor in a renal wrap hypertension model. Hypertension. 1999;33:1237-1242.
22. Siragy HM, De Gasparo M, Carey RM. Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension. 2000;35:1074-1077.
23. De Mey C, Vanhoutte PM. Effect of age and spontaneous hypertension on the tachyphylaxis to 5-hydroxytryptamine and angiotensin II in the isolated rat kidney. Hypertension. 1981;3:718-724.
24. 1 receptor blockers in isolated vessels of different origin. Hypertension. 1999;33:1406-1413.
25. 1 receptor blockade in SHR. Hypertension. 2001;37:91-98.
26. Halpern W, Kelley M. In vitro methodology for resistance arteries. Blood Vessels. 1991;28:245-251.
27. Loufrani L, Matrougui K, Gomy D, Duriez M, Blanc I, Levy BI, Henrion D. Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin. Circulation. 2001;103:864-870.
28. Matrougui K, Levy BI, Schiavi P, Guez D, Henrion D. Indapamide improves flow-induced dilation in hypertensive rats with a high salt intake. J Hypertens. 1998;16:1485-1490.
29. 2 receptor in PC12W cells. Regul Pept. 1993;44:207-213.
30. 1 receptor antagonist in conscious spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2001;28:A45.
31. Thomas WG. Regulation of angiotensin II type 1 receptor function. Regulat Pept. 1999;79:9-23.
32. Mukoyama M, Horiuchi M, Nakajima M, Pratt RE, Dzau VJ. Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells. Mol Cell Endocrinol. 1995;112:61-88.
33. 2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol. 1997;11:1266-1277.
34. Tea BS, Der Sarkissian S, Touyz RM, Hamet P, deBlois D. Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. Hypertension. 2000;35:1069-1073.